EMA601 and glenzocimab: two glycoprotein VI inhibitory Fabs with different potency
- Eur Heart J. 2025 Jul 21;46(28):2827-2828. doi: 10.1093/eurheartj/ehaf162.
Affiliations
- 1. Institute of Experimental Biomedicine I, Würzburg Josef-Schneider-Straße 2, 97080 Würzburg, Germany.
- 2. Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians University of Würzburg Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
PMID: 40171679
DOI: 10.1093/eurheartj/ehaf162
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Glycoprotein VIResearch Areas: Cardiovascular Disease